Centaurus Financial Inc. Has $321,000 Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Centaurus Financial Inc. cut its stake in DocuSign, Inc. (NASDAQ:DOCUFree Report) by 24.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,995 shares of the company’s stock after selling 1,970 shares during the period. Centaurus Financial Inc.’s holdings in DocuSign were worth $321,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Massmutual Trust Co. FSB ADV raised its stake in DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $27,000 after acquiring an additional 500 shares in the last quarter. Mather Group LLC. grew its holdings in shares of DocuSign by 4,338.5% in the 2nd quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Register Financial Advisors LLC acquired a new stake in shares of DocuSign during the 1st quarter worth about $37,000. nVerses Capital LLC bought a new position in DocuSign during the 2nd quarter valued at about $48,000. Finally, Quarry LP bought a new position in DocuSign during the 2nd quarter valued at about $53,000. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at DocuSign

In related news, CEO Allan C. Thygesen sold 7,648 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total value of $477,770.56. Following the completion of the transaction, the chief executive officer now directly owns 115,589 shares of the company’s stock, valued at approximately $7,220,844.83. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Robert Chatwani sold 14,799 shares of DocuSign stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total transaction of $820,752.54. Following the completion of the sale, the insider now owns 70,748 shares of the company’s stock, valued at approximately $3,923,684.08. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Allan C. Thygesen sold 7,648 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total value of $477,770.56. Following the completion of the transaction, the chief executive officer now directly owns 115,589 shares in the company, valued at $7,220,844.83. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 445,802 shares of company stock valued at $23,829,559. Company insiders own 1.66% of the company’s stock.

DocuSign Trading Up 1.4 %

Shares of NASDAQ DOCU opened at $63.84 on Friday. The firm’s 50-day moving average is $57.00 and its 200-day moving average is $56.52. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76. The firm has a market capitalization of $13.07 billion, a PE ratio of 122.77, a price-to-earnings-growth ratio of 6.37 and a beta of 0.92.

DocuSign (NASDAQ:DOCUGet Free Report) last announced its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. During the same period last year, the company posted $0.09 EPS. DocuSign’s revenue for the quarter was up 7.0% on a year-over-year basis. As a group, equities research analysts anticipate that DocuSign, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Bank of America upped their price objective on shares of DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Royal Bank of Canada increased their price target on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research report on Friday, September 6th. Robert W. Baird lifted their price objective on DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. JMP Securities restated a “market outperform” rating and set a $84.00 target price on shares of DocuSign in a report on Thursday, September 5th. Finally, Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research note on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, DocuSign currently has a consensus rating of “Hold” and a consensus target price of $63.40.

Get Our Latest Stock Analysis on DOCU

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.